In addition, we collected multiple datasets and performed K‐M survival analyses and found that higher GLO1 expression levels were significantly associated with a more unfavorable prognosis in patients with breast cancer (Figure 5M; Figure S6F, Supporting Information). The gene discussed is GLO1; the disease is breast carcinoma.